When was Astellas Venture Management founded?

Astellas Venture Management was founded in 2005.

Where is Astellas Venture Management headquartered?

Astellas Venture Management is headquartered in South San Francisco, CA.

What is Astellas Venture Management's total asset value?

Astellas Venture Management has around in total assets under management.

How many investments has Astellas Venture Management made?

Astellas Venture Management has made 108 investments.

What has Astellas Venture Management invested in?

Astellas Venture Management has made numerous investments in companies like Syntax Bio , ResNovas Therapeutics , and Restore Vision within the Drug Discovery industry.

What has Astellas Venture Management invested in recently?

Astellas Venture Management's latest investment was on 21-Jun-2026 in Syntax Bio , a company within the Drug Discovery industry.

Astellas Venture Management investment portfolio

Astellas Venture Management Overview

Investor Type

Venture Capital

Status

Active

Professionals

5

Investments

108

Portfolio

20

Exits

62

Astellas Venture Management General Information

Company Description

Founded in 2005, Astellas Venture Management is the corporate venture arm of Astellas Pharma headquartered in Brisbane, California. The firm seeks to invest in early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development.

Business Details

Website

www.astellasventure.com

Year Founded

2005

Investor Status

Actively Seeking New Investments

Primary Investor Type

Corporate Venture Capital

Corporate Office

480 Forbes Boulevard
South San Francisco, CA 94080
United States

+1 (650)

Astellas Venture Management Investments & Acquisitions (108)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Syntax Bio	21-Jun-2026	Later Stage VC	Drug Discovery	Pre-Clinical Trials
ResNovas Therapeutics	01-May-2026		Drug Discovery	Pre-Clinical Trials
Restore Vision	15-Apr-2026		Drug Discovery	Clinical Trials - General
Sidewinder Therapeutics	25-Mar-2026		Drug Discovery	Generating Revenue
Solu Therapeutics	09-Apr-2025		Drug Discovery	Clinical Trials - Phase 1
PhoreMost	10-Sep-2024		Drug Discovery	Pre-Clinical Trials
Cellular Intelligence	09-Sep-2024		Drug Discovery	Generating Revenue
Toregem Biopharma	29-Aug-2024		Drug Discovery	Clinical Trials - Phase 1
Shinobi Therapeutics	01-Aug-2024	Early Stage VC	Drug Discovery	Pre-Clinical Trials
Turn Biotechnologies	10-May-2024	Later Stage VC	Drug Discovery	Pre-Clinical Trials

You’re viewing 10 of 108 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astellas Venture Management Exits (62)

Company Name	Exit Date	Exit Type
Turn Biotechnologies	21-May-2026	Merger/Acquisition
Orna Therapeutics	01-May-2026
DigiTx Partners	01-Feb-2026
JBeam	29-Sep-2025
Crescendo Biologics	24-Jul-2023
Tizona Therapeutics	01-Dec-2022
F2G	04-Aug-2022
Seldar Pharma	01-Jun-2022
Viamet Pharmaceuticals Holdings	10-Jan-2022	Out of Business
Effector Therapeutics	25-Aug-2021	Reverse Merger

You’re viewing 10 of 62 exits. Get the full list »

Astellas Venture Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.